177 related articles for article (PubMed ID: 23994130)
1. Analytical challenges for conducting rapid metabolism characterization for QIVIVE.
Tolonen A; Pelkonen O
Toxicology; 2015 Jun; 332():20-9. PubMed ID: 23994130
[TBL] [Abstract][Full Text] [Related]
2. Biotransformation in vitro: An essential consideration in the quantitative in vitro-to-in vivo extrapolation (QIVIVE) of toxicity data.
Wilk-Zasadna I; Bernasconi C; Pelkonen O; Coecke S
Toxicology; 2015 Jun; 332():8-19. PubMed ID: 25456264
[TBL] [Abstract][Full Text] [Related]
3. Quantitative in vitro to in vivo extrapolation (QIVIVE): An essential element for in vitro-based risk assessment.
Yoon M; Blaauboer BJ; Clewell HJ
Toxicology; 2015 Jun; 332():1-3. PubMed ID: 25680635
[No Abstract] [Full Text] [Related]
4. Quantitative in vitro-to-in vivo extrapolation in a high-throughput environment.
Wetmore BA
Toxicology; 2015 Jun; 332():94-101. PubMed ID: 24907440
[TBL] [Abstract][Full Text] [Related]
5. The long and winding road of progress in the use of in vitro data for risk assessment purposes: From "carnation test" to integrated testing strategies.
Blaauboer BJ
Toxicology; 2015 Jun; 332():4-7. PubMed ID: 24769060
[TBL] [Abstract][Full Text] [Related]
6. Gaining acceptance for the use of in vitro toxicity assays and QIVIVE in regulatory risk assessment.
Meek ME; Lipscomb JC
Toxicology; 2015 Jun; 332():112-23. PubMed ID: 25598226
[TBL] [Abstract][Full Text] [Related]
7. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
[TBL] [Abstract][Full Text] [Related]
8. Dose metric considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations.
Groothuis FA; Heringa MB; Nicol B; Hermens JL; Blaauboer BJ; Kramer NI
Toxicology; 2015 Jun; 332():30-40. PubMed ID: 23978460
[TBL] [Abstract][Full Text] [Related]
9. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
[TBL] [Abstract][Full Text] [Related]
10. Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results.
Yoon M; Campbell JL; Andersen ME; Clewell HJ
Crit Rev Toxicol; 2012 Sep; 42(8):633-52. PubMed ID: 22667820
[TBL] [Abstract][Full Text] [Related]
11. The development and assessment of high-throughput mass spectrometry-based methods for the quantification of a nanoparticle drug delivery agent in cellular lysate.
Buse J; Purves RW; Verrall RE; Badea I; Zhang H; Mulligan CC; Peru KM; Bailey J; Headley JV; El-Aneed A
J Mass Spectrom; 2014 Nov; 49(11):1171-80. PubMed ID: 25395133
[TBL] [Abstract][Full Text] [Related]
12. Toxicology is IN: in silico, in vitro, integrated testing strategy.
Caloni F; Benfenati E; Sambuy Y
ALTEX; 2016; 33(2):187-8. PubMed ID: 27032091
[No Abstract] [Full Text] [Related]
13. An integrated bioanalytical platform for supporting high-throughput serum protein binding screening.
Zhang J; Shou WZ; Vath M; Kieltyka K; Maloney J; Elvebak L; Stewart J; Herbst J; Weller HN
Rapid Commun Mass Spectrom; 2010 Dec; 24(24):3593-601. PubMed ID: 21080511
[TBL] [Abstract][Full Text] [Related]
14. Analytical strategies for identifying drug metabolites.
Prakash C; Shaffer CL; Nedderman A
Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
[TBL] [Abstract][Full Text] [Related]
15. Incorporating population variability and susceptible subpopulations into dosimetry for high-throughput toxicity testing.
Wetmore BA; Allen B; Clewell HJ; Parker T; Wambaugh JF; Almond LM; Sochaski MA; Thomas RS
Toxicol Sci; 2014 Nov; 142(1):210-24. PubMed ID: 25145659
[TBL] [Abstract][Full Text] [Related]
16. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.
Kostiainen R; Kotiaho T; Kuuranne T; Auriola S
J Mass Spectrom; 2003 Apr; 38(4):357-72. PubMed ID: 12717747
[TBL] [Abstract][Full Text] [Related]
17. Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment.
Wetmore BA; Wambaugh JF; Ferguson SS; Sochaski MA; Rotroff DM; Freeman K; Clewell HJ; Dix DJ; Andersen ME; Houck KA; Allen B; Judson RS; Singh R; Kavlock RJ; Richard AM; Thomas RS
Toxicol Sci; 2012 Jan; 125(1):157-74. PubMed ID: 21948869
[TBL] [Abstract][Full Text] [Related]
18. LC-MS (/MS) in clinical toxicology screening methods.
Viette V; Hochstrasser D; Fathi M
Chimia (Aarau); 2012; 66(5):339-42. PubMed ID: 22867548
[TBL] [Abstract][Full Text] [Related]
19. A review of LC-MS techniques and high-throughput approaches used to investigate drug metabolism by cytochrome P450s.
Youdim KA; Saunders KC
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1326-36. PubMed ID: 20207203
[TBL] [Abstract][Full Text] [Related]
20. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
